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Estrogen replacement therapy (ERT) is a common 
prescription for females during post-menopause, but 
ERT efficacy remains debatable (Webber et al. 2004). 
Additionally, unipolar and bipolar disorders occur dur-
ing menopause and as a result, women are prescribed 
mood stabilizers in combination with ERT (Burt and 
Rasgon 2004, Soares and Taylor 2007). Few studies 
focus on the interacting properties of hormones and 
mood stabilizers. The paucity of studies is regrettable 
since both hormones and mood stabilizers influence a 
myriad of cell signaling pathways by either initiating 
protein signaling cascades or by modulating these cas-
cades via activating and/or inhibiting specific proteins 
(McEwen 2001, Jope 2003). Estrogen is diminished dur-
ing menopause (Blake 2006) and this depletion not only 
affects women physiologically but also has neurological 
implications such as enhancing neurodegeneration, 
reducing synaptic connectivity, and cognitive decline 
(Gandy 2003). Studies show that estrogen reduces astro-
cytosis, increases cell proliferation and differentiation of 
neurons potentially mediated via estrogen receptors (see 
McEwen 2001, Saravia et al. 2007). A plethora of protein 
signaling cascades are facilitated by estrogen resulting 
in gene expression for cell survival, as well as for learn-
ing and memory mechanisms among glia and neurons 
(McEwen 2001). Estrogen receptor α and β (ER-α and 
ER-β) play roles in facilitating estrogen-mediated glia 
through extracellular-regulated kinase and phosphati-
dylinositol 3-kinase/Akt protein signaling (Dhandapani 
and Brann 2007), as well as neuronal protein signaling 
cascades (McEwen 2001). Studies also show pyramidal 
cells of rat hippocampus co-express brain derived neu-
rotrophic factor (BDNF) and ER-α  (Solum and Handa 
2002), and BDNF drastically decreases in people suffer-
ing from neurodegenerative disorders (Sohrabji and 
Lewis 2006). Estrogen, via ER-α, increases BDNF 
expression and facilitates BDNF-tyrosine kinase recep-
tor signaling in both glia and neurons (Sohrabji and 
Lewis 2006). Anti-apoptotic factors are also affected by 
ER-α. Also, astrocytic co-expression of B-cell lympho-
ma/leukemia-2 and ER-α in the hippocampus of post-
mortem brains of Alzheimer’s disease (AD) patients 
indicates a potential mechanism for ER-α neuroprotec-
tion (Dhandapani and Brann 2007). Further, ER-α 
expression increases in the hippocampus of AD patients 
compared with controls (Lu et al. 2003). 
Lithium is commonly used to treat bipolar disorder 
(an adjuvant for depression), and is identified as a spe-
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cific inhibitor of glycogen synthase kinase-3-beta 
(GSK-3β) (Klein and Melton 1996). Molecular implica-
tions for lithium continue to be explored. Similar to 
estrogen, lithium facilitates gene expression responsi-
ble for anti-apoptosis, and mechanisms of learning and 
memory (Manji et al. 1999). Among neurons, lithium-
facilitated-GSK-3β inhibition is associated with reduc-
ing apoptosis (Hongisto et al. 2003), increasing neu-
rotrophic factors (Angelucci et al. 2003), increasing 
dopamine receptor subunit 2 (Dziedzicka-Wasylewska 
and Wędzony 1996), and facilitating DNA binding of 
transcription factors (Grimes and Jope 2001). Lithium 
also affects astrocytic pH levels that stimulate myo-
inositol transport systems, ultimately affecting protein 
signaling pathways in astrocytes (Song et al. 2008). 
Inositol signaling is known to be regulated by proline-, 
glutamic acid-, and leucine-rich protein-1, a co-regula-
tor of ER-α signaling (Nair and Vadlamudi 2007). 
We recently published results of a study that focused 
on combined effects of estradiol (17β-estradiol; E2) 
and lithium chloride (LiCl) (E2/LiCl) on glial NMDAR 
subunit NR1 gene expression and glutamate excitotox-
icity. We showed that a 48 h E2/LiCl treatment reduced 
NR1 gene expression and increased glutamate excito-
toxicity in mouse hippocampal and cortical primary 
cultures of mixed brain cells predominated by glia 
(Valdés and Weeks 2009). In the present study, we use 
the same cDNA from treated primary mixed brain cell 
cultures of our previous study to further investigate 
how combined E2/LiCl influence ER-α gene expres-
sion. Our results indicate that after 48 h, E2/LiCl treat-
ment increases ER-α mRNA in C57BL/6J mouse pri-
mary mixed hippocampal cell cultures. We recognize 
that since results are generated from embryonic brain 
cell cultures, such introduces considerations for pro-
cesses in development. Still, we believe our results will 
initiate other investigations to elucidate how hormones 
and mood stabilizer interact and how they affect brain 
gene expression and proteins.
Florida International University Institutional Animal 
Care and Use Committee approved all experiments 
described in this study (IACUC protocol #: 08-017). 
For a detailed description of experimental procedures, 
refer to our previous study (Valdés and Weeks 2009). 
Briefly, primary mixed hippocampal and cortical cul-
tures were harvested from E18.5 C57BL/6J mice. 
Disassociated cells were randomly plated (6×106 for 
cortical cultures and 3×106 for hippocampal cultures) 
on poly-D-lysine (100 µg/mL; Sigma-Aldrich, Missouri) 
coated 12-well plates containing B27/Neurobasal medi-
um (Invitrogen, California) with 0.5mM L-glutamine 
and 4µg/mL gentamicin. Cells were maintained in a 
humidified, 5% CO2 atmosphere incubator with a set 
temperature of 37°C. Additional 12-well plates, with 
poly-D-lysine (100 µg/mL) coated coverslips were set 
aside for immunocytochemical purposes. After 4 days 
in culture, the media was removed entirely and replaced 
with fresh media; half of the media was changed every 
4 days, thereafter, until E2 and/or LiCl treatment. After 
twelve days in culture, the media was removed entirely 
and replaced with media treated with 10 mM LiCl 
(Sigma-Aldrich, Missouri), 0.04 µM E2  (Sigma-
Aldrich, Missouri), or combined E2/LiCl and duration 
of treatment for each group was 48 h. We chose these 
specific concentrations for E2 and LiCl, and a 48 h 
treatment period based on our previous findings (Valdés 
and Weeks 2009). 
Primary mixed cultures were immunolabeled using 
neurofilament-H (NF-H) (Upstate, Virginia) and glia 
fibrillary acidic protein (GFAP) (Sigma-Aldrich, 
Missouri) antibodies. Cells were fixed with 4% para-
formaldehyde and permeabilized for 30 min at room 
temperature with 0.25% DPBST (DPBS with 0.25% 
[v/v] Triton X-100). Non-specific binding sites were 
blocked with 10% normal goat serum overnight at 4°C. 
Primary cultures were then incubated at room tem-
perature with mouse NF-H or GFAP antibodies and 
visualized using fluorescent-conjugated secondary 
antibodies. Cells were counterstained with Hoechst 
33342 to reveal nuclei, coverslips were mounted on 
glass slides, and sealed with clear nail polish. Images 
were captured using a Leica Leitz DM RB fluorescent 
microscope with a Leica DM 500 camera (Leica, 
Bannockburn, IL, USA). 
Total RNA was isolated from cultures using TRIzol 
reagent (GIBCO, California), according to manufac-
turer’s protocol. Briefly, cultures were rinsed with ice-
cold DPBS, TRIzol (600 µL - 1 mL) was added 
directly into each well, and then homogenized. 
Homogenized cells were transferred to a fresh tube, 
and incubated at room temperature. Chloroform was 
added and centrifuged at 6,700 x g at 4°C. Total RNA 
(aqueous phase) was precipitated with isopropanol and 
glycogen overnight at -20°C. RNA was pelleted via 
centrifugation at 6,700 x g at 4°C, supernatant decant-
ed and RNA pellet washed with 75% ethanol, then 
resuspended with DEPC-treated water. DNA contami-
nants were removed with the RQ1 DNase kit (Promega, 
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Wisconsin). Total RNA was then reverse transcribed 
(RT) using SUPERSCRIPTTM II RNase H-free reverse 
transcriptase (Invitrogen, California), according to the 
manufacturer’s protocol. Briefly, 500 ng of total RNA 
was reverse transcribed with 0.05 µg/µl of Oligo(dT)12-
18 at 65°C for 5 min. First strand cDNA was synthesized 
with 5 mM MgCl2, 10 mM DTT, and 2.5 units 
Superscript II and incubated at 42°C for 50 min and 
terminated at 70°C for 15 min. RNase H (Invitrogen, 
California) was added to cDNA to remove any remain-
ing RNA by incubating at 37°C for 20 min.
First strand cDNA was amplified via real time PCR 
using SYBR Green PCR master mix (ABgene, New 
York), 200-300nM of forward and reverse primers 
using AB 7300 qPCR apparatus. Cycling parameters 
were set at: 95°C for 15 s, 57°C or 63°C for 30 s, and 
extension at 72°C for 30 s, for a total of 40 cycles, fol-
lowed by a final extension at 72°C for 10 min. The 
specific primer pairs were: ER-α: forward primer, 
5’-AAGGGCAGTCACAATGAACC-3’; reverse prim-
er, 5’-GCCAGGTCATTCTCCACATT-3’; HPRT: for-
ward primer, 5’-GGAGCGGTAGCACCTCCT-3’; 
reverse primer, 5’-AATCCAGCAGGTCAGCAAAG-3’. 
All samples were compared with a standard curve 
comprised of pDNA of HPRT and ER-α generated 
using TOPO TA Cloning® Kit (Invitrogen, California). 
Readings were normalized by dividing mRNA start-
ing quantity (SQ) of ER-α by the house-keeping gene 
HPRT mRNA SQ; output is in picograms (pg) of 
mRNA. Data are presented as the mean ± S.E.M and 
statistical significances were determined by an analy-
sis of variance (ANOVA) followed by Bonferroni’s 
post-hoc testing. Significant differences have a 
P-value<0.05. All results were obtained from two 
separate experimental procedures with factors and 
levels randomly determined.
We chose to analyze mRNA expression since both 
estrogen and lithium indirectly and/or directly affect 
genomic responses (McEwen 2001, Jope 2003). 
Quantitative RT-PCR results indicate that ER-α mRNA 
expression significantly differs depending on cell cul-
ture type (F1,8=32.59, P<0.001) – hippocampal cultures 
express higher levels of mRNA compared with cortical 
cultures (Fig. 1). We also noted significant difference 
in treatment type (F3,8=5.73, P<0.025), and the interac-
tion between treatment and cell culture type (F3,8=5.6, 
P<0.025). Bonferroni’s post-hoc testing indicated that 
combined E2/LiCl significantly increases (P<0.05) 
Fig. 1: Real time RT-PCR of ER-α mRNA expression. E18.5 hippocampal (grey bars) and cortical (black bars) primary cell 
cultures were treated for 48 h with 0.04 µM E2, 10 mM LiCl, combined E2/LiCl, or Control (no treatment). After treatment 
total RNA was isolated and reverse transcribed. Expression for each gene was normalized using the house-keeping gene 
HPRT. The figure denotes normalized mRNA expression in picograms (y-axis) and treatment type (x-axis). *, P<0.05 com-
pared with control; #, P<0.05 compared with E2.
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ER-α mRNA expression compared with control and 
E2 treated hippocampal cultures; E2 or LiCl alone 
does not significantly alter ER-α mRNA expression 
(Fig. 1). Figure 1 also shows no significant differences 
in ER-α mRNA expression across treatments for corti-
cal cell cultures (F3,4=0.341, P>0.75). 
Immunocytochemical images (Fig. 2A) depict high 
GFAP expression in hippocampal cultures and by 
design with low NF-H labeling – as noted by the unla-
beled surrounding nuclei (Fig. 2B). This coincides 
with our previous findings that these primary mixed 
brain cell cultures express high glia-specific mRNA 
(Valdés and Weeks 2009). Glia predominates in the 
brain and investigations on how estrogen and lithium 
affect glial molecular mechanisms are essential for 
developing translational studies that could benefit 
post-menopausal women. Glia do express ER-α and 
expression levels of ER-α vary according to the neuro-
anatomical region and developmental stage: low levels 
of ER-α are express in the cortex and hippocampus 
(Shughrue et al. 1997). Our results (Fig. 1) concur 
with studies that show murine hippocampus exhibit-
ing higher levels of ER-α than the cortex (Mitra et al. 
2003). 
Fig. 2A-2B: Immunocytochemical images of hippocampal cultures labeled with GFAP (A; 200X) and; NF-H (B; 400X) 
antibodies (green). All nuclei are labeled with Hoechst stain (blue). Scale bar = 2µm.
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In our previous study we showed that LiCl reduces 
NMDA subunit NR1 mRNA expression in E2-treated 
cultures (Valdés and Weeks 2009). In the present study 
we show that E2/LiCl-treated cultures show increases 
in ER-α mRNA expression, however, E2 or LiCl alone 
does not significantly alter ER-α mRNA expression 
(Fig. 1). Under conditions of neuronal damage, ER-α 
expression increases among neonate rat cortical astro-
cytes, mediated by E2, and this increase aids damaged 
neurons (Carbonaro et al. 2009). Cortical ER-α mRNA 
expression was not affected by our treatment parame-
ters, though (Fig. 1). Our cortical cultures did express 
higher glia-specific mRNA than hippocampal (Valdés 
and Weeks 2009) and we report in the present study 
that primary hippocampal cultures show high per-
ikaryon labeling of NF-H (Fig. 2B), which is indicative 
of neuronal apoptosis (Lee et al. 1999). Additionally, 
studies show that combined estrogen and lithium 
increase serotonin in ovariectomized rat striatal and 
frontal cortex (Morissette and Di Paolo 1996) and 
serotonin augments neurogenesis (Djavadian 2004). 
Studies depicting co-localization of ERs among prolif-
erating cells of the dentate gyrus suggest a direct 
estrogen/ER-interaction modulating neurogenesis 
(Isgor and Watson 2005). Our study may serve as a 
platform to further investigate how combined E2/LiCl 
effects neurogenesis – a topic scarcely explored. 
Recent studies using neuronal cell lines show that 
ER-α gene expression has an E2 dose dependency – 
reducing ER-α gene expression within 16 h treatment of 
0.1 µM E2 (Ng et al. 2009). Other studies indicate that 
ER-α increases in neonatal rat hippocampus with E2 
treatment (Rune et al. 2002). Furthermore, fluxes in 
ER-α expression levels raises developmental consider-
ations since ER-α expression in rat brain is high during 
prenatal day 9, declines then increases at the neonatal 
stage and then declines again with age (Su et al. 2001); 
this occurs in both the hippocampus and cortex (González 
et al. 2007). Our cultures are from embryonic mouse 
brain (E18.5) and this developmental factor may account 
for differences noted in other publications, but we found 
no significant differences in ER-α mRNA expression 
with E2 or LiCl individual treatment (Fig. 1). Our results 
are generated and interpreted at the transcriptional level 
but these results indicate that some molecular mecha-
nism responsible for ER-α transcription is being altered 
due to the combined treatment of estrogen and lithium. 
We believe, however, knowledge on how estrogen and 
lithium interact will provide a better understanding on 
related molecular mechanisms affected by combined 
ERT and mood stabilizing treatment regiments.
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